Abstract
Cefamandole pharmacokinetics were investigated in 24 adult males with stable renal function and creatinine clearances of 0 to 139 ml/min. After intramuscular injection of 1.0 g of cefamandole, peak plasma concentrations were achieved between 1 and 2 h. Maximum plasma concentration and drug half-life increased as creatinine clearance decreased; i.e., with normal renal function the half-life was 1.49 ± 0.10 h, and in anephrics the half-life was 11.48 ± 1.91 h. The greatest increase in half-life occurred when the creatinine clearance was less than 20 ml/min. At these levels of renal impairment, there was significant variance in calculated half-life among patients. The maximum urine concentration and rate of cefamandole urinary excretion decreased as renal function declined. Evidence suggesting renal and nonrenal methods of drug elimination is presented. Hemodialysis resulted in increased cefamandole elimination.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bryan C. S., Stone W. J. Antimicrobial dosage in renal failure: a unifying nomogram. Clin Nephrol. 1977 Feb;7(2):81–84. [PubMed] [Google Scholar]
- Dettli L., Spring P., Habersang R. Drug dosage in patients with impaired renal function. Postgrad Med J. 1970 Oct;(Suppl):32–35. [PubMed] [Google Scholar]
- Griffith R. S., Black H. R., Brier G. L., Wolny J. D. Cefamandole: in vitro and clinical pharmacokinetics. Antimicrob Agents Chemother. 1976 Nov;10(5):814–823. doi: 10.1128/aac.10.5.814. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mellin H. E., Welling P. G., Madsen P. O. Pharmacokinetics of cefamandole in patients with normal and impaired renal function. Antimicrob Agents Chemother. 1977 Feb;11(2):262–266. doi: 10.1128/aac.11.2.262. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Meyers B. R., Hirschman S. Z. Pharmacokinetics of cefamandole in patients with renal failure. Antimicrob Agents Chemother. 1977 Feb;11(2):248–250. doi: 10.1128/aac.11.2.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Meyers B. R., Ribner B., Yancovitz S., Hirschman S. Z. Pharmacological studies with cefamandole in human volunteers. Antimicrob Agents Chemother. 1976 Jan;9(1):140–144. doi: 10.1128/aac.9.1.140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ratzan K. R., Baker H. B., Lauredo I. Excretion of cefamandole, cefazolin, and cephalothin into T-tube bile. Antimicrob Agents Chemother. 1978 Jun;13(6):985–987. doi: 10.1128/aac.13.6.985. [DOI] [PMC free article] [PubMed] [Google Scholar]